Skip Nav Destination
Close Modal
1-20 of 2019 Search Results for
standard
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Journal Article
J Health Polit Policy Law (1988) 13 (4): 635–662.
Published: 01 August 1988
...: National Academy Press. Toward a Definitive Antitrust Standard
for Nonprofit Hospital Mergers
William G. Kopit and Robert W McCann, Epstein Becker
& Green, P.C.
Abstract. Despite decades of federal and state regulatory efforts...
Journal Article
J Health Polit Policy Law (1991) 16 (1): 1–18.
Published: 01 February 1991
...James C. Robinson; Dalton G. Paxman In 1989, after almost two decades of substance-by-substance standard setting, the Occupational Safety and Health Administration (OSHA) promulgated its Air Contaminants Standard, imposing new exposure limits for 376 toxic substances encountered in U.S. industry...
Journal Article
J Health Polit Policy Law (2011) 36 (5): 829–853.
Published: 01 October 2011
..., it also provides subsidies to ensure that health insurance premiums are affordable. However, relatively little work has been done on how such affordability standards should be set. The existing literature on affordability is not grounded in social norms and has methodological and theoretical flaws...
Image
in Polarization, the Pandemic, and Public Trust in Health System Actors
> Journal of Health Politics, Policy and Law
Published: 01 June 2024
Figure 1 Mean (standard error) trust in a number of health care actors. Source : YouGov original survey, July 2023.
More
Image
in Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i Loophole
> Journal of Health Politics, Policy and Law
Published: 01 December 2022
Figure 2 Difference in estimated 2017 Medicaid rebates for Humira under standard AMP and 5i AMP methodologies. Notes : AMP = average manufacturer price. The figure shows the difference in Medicaid rebates per unit of Humira in 2017 between the standard methodology (left) and the 5i methodology
More
Image
in Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i Loophole
> Journal of Health Politics, Policy and Law
Published: 01 December 2022
Figure 3 Difference in AMP and Medicaid rebates per unit of Humalog under standard AMP and 5i AMP methodologies, 2013–2017. Panel A Difference in AMP estimates. Panel B Difference in Medicaid rebates. Notes : PBM = pharmaceutical benefit manager; AMP = average manufacturer price. 5i AMP
More
Journal Article
J Health Polit Policy Law (1995) 20 (1): 137–169.
Published: 01 February 1995
... that are relevant to the merger guidelines among challenged and unchallenged mergers. We found that (1) the specific standards articulated in the merger guidelines do not provide good predictability of when a hospital merger challenge would occur, and (2) comparisons of challenged and unchallenged mergers...
Journal Article
J Health Polit Policy Law (1982) 7 (3): 629–647.
Published: 01 June 1982
...Giandomenico Majone This paper explores some significant sources of variation in the way health standards are derived and used in various countries: differences in biological and regulatory philosophies, in enforcement strategies, and in institutional arrangements. Such cross-national variations...
Journal Article
J Health Polit Policy Law (1979) 4 (3): 414–434.
Published: 01 June 1979
... standards. Empirical eivdence concerning the effect of regulation on provider incomes and the relationship between reported compliance with standards and provider operating costs is examined. In the latter case, the evidence is consistent with a self-interest theory of behavior for regulatory agencies...
Journal Article
J Health Polit Policy Law (2017) 42 (4): 607–644.
Published: 01 August 2017
... to all new tobacco products, based on a public health standard, before they can be legally marketed. Yet the law also contains an alternative pathway for market entry—the substantial equivalence (SE) clause—by which novel and altered tobacco products can be marketed by demonstrating their substantial...
FIGURES
Journal Article
J Health Polit Policy Law (1981) 6 (1): 136–158.
Published: 01 February 1981
...Douglas A. Hastings The degree of confidentiality to be accorded data gathered and analyzed by Professional Standards Review Organizations (PSROs) in the course of their medical peer review activities is a crucial and controversial issue in health policy. In late 1977, a consumer organization...
Journal Article
J Health Polit Policy Law (1994) 19 (2): 423–447.
Published: 01 April 1994
...–1986. Paper presented at the RAND Conference on Health Economics, Santa Monica, CA, 2 March. Hospitals and Antitrust:
Defining Markets, Setting Standards
Jack Zwanziger...
Journal Article
J Health Polit Policy Law (2021) 46 (5): 831–860.
Published: 01 October 2021
...Ari Ne'eman; Michael Ashley Stein; Zackary D. Berger; Doron Dorfman Abstract Context: COVID-19 has prompted debates between bioethicists and disability activists about Crisis Standards of Care plans (CSCs), triage protocols determining the allocation of scarce lifesaving care. Methods: We examine...
FIGURES
Includes: Supplementary data
Journal Article
J Health Polit Policy Law (1981) 6 (2): 255–284.
Published: 01 April 1981
... standards for disclosure, as well as a third standard intended to capture their normative sense of what should be disclosed to patients. Other factors which might affect disclosure practices of physicians were also studied. The findings raise questions about the extent to which a legal standard...
Image
in Social Determinants and Disparities in Health: Their Crucifixion, Resurrection, and Ultimate Triumph(?) in Health Policy
> Journal of Health Politics, Policy and Law
Published: 01 August 2016
Figure 3 Respiratory Tuberculosis: Mean Annual Death Rates (Standardized to 1901 Population) in England and Wales Source : McKeown 1988
More
Journal Article
J Health Polit Policy Law (2022) 47 (6): 853–877.
Published: 01 December 2022
...% sample of Medicare Part D beneficiaries to evaluate the current spending distribution across different payers for different types of beneficiaries across different benefit phases. They then model how these estimates would change under a proposal to redesign the Medicare Part D standard benefit. Findings...
FIGURES
| View All (8)
Journal Article
J Health Polit Policy Law (1979) 4 (3): 435–463.
Published: 01 June 1979
...Judith Feder; Bruce Spitz This paper analyzes the politics of hospital payment over the last decade. The authors explain how provider interests and judgments became a standard for appropriate hospital payment; the impact of that standard on hospital costs; and the political obstacles to imposing...
Journal Article
J Health Polit Policy Law (1986) 11 (1): 41–66.
Published: 01 February 1986
...Glenn L. Pierce; Mary L. Durham; William H. Fisher This paper examines the impact of broadened Washington state civil commitment standards on utilization of the state's mental hospitals. Included in the analysis is an assessment of the impact of a public event (a well-publicized murder case) which...
Journal Article
J Health Polit Policy Law (2014) 39 (4): 781–809.
Published: 01 August 2014
...Charlene Harrington; Julie Stockton; Sarah Hooper Abstract This article examines the effects of state regulation and civil class action litigation on corporate compliance with nurse staffing and quality standards, corporate strategies to manage staffing and quality, and corporate financial status...
Journal Article
J Health Polit Policy Law (1988) 13 (2): 263–278.
Published: 01 April 1988
...Joseph P. Newhouse This paper updates tests of the validity of three models of medical price inflation: a standard model, in which changes in demand press against inelastic supply; a dynamic version of the standard model, in which high levels of insurance induce high rates of product innovation...
1
